A US Navy Global Autonomous Reconnaissance Craft (GARC) maneuvers in the Atlantic Ocean during UNITAS 2025 on Sept. 23, 2025. US Navy photo ARLINGTON, Va. — A new office consolidating the development ...

Model making is a great hobby, but knowing how and where to start is another story. It can be overwhelming for novices: Injection-molded plastic models have been on the market for close to a century, ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

Even though it might seem like Tesla has a lot going on—robotaxis, literal humanoid robots, and that ever-elusive affordable model that just keeps getting pushed back—its aging core lineup has only ...

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. Baraka is perhaps the most interesting personality in a crowded Democratic primary to ...

Forbes contributors publish independent expert analyses and insights. I write about the economics of AI. The AI boom has been defined by unprecedented innovation across nearly every sector. From ...

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...

Ras Baraka, the Democratic mayor of Newark, New Jersey, and a candidate for governor, appeared in federal court Thursday for a status conference after being arrested at an ICE facility last week on a ...

Newark, New Jersey Mayor Ras Baraka was briefly arrested at an ICE detention center. The arrest occurred during an unannounced inspection by members of New Jersey's congressional delegation. Baraka, a ...

KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...